Diabetic Drugs for Weight Loss: What Works and Who Can Use Them (October 2026)

01

Which diabetic drugs help with weight loss?

The diabetic drugs that support weight loss are mainly the injectable medicines that act on gut hormones, because they reduce appetite and slow how quickly the stomach empties. Mounjaro is licensed for weight management in adults and for type 2 diabetes, and it improves blood sugar control (HbA1c) while supporting weight loss.¹

That does not mean every diabetes tablet or injection leads to weight loss. Different medicines act in different ways, and some people notice no change or an opposite effect. Your diabetes team knows which medicines you take and why.

If you want a deeper look at the question of weight change on diabetes treatment, our guide on whether diabetic medication causes weight loss covers it in more detail, and our overview of the diabetic weight loss drug question looks at the licensed options.

02

Is this relevant to you, and what should you do next?

This is relevant to you if you have diabetes and want to lose weight, or if you are considering weight-loss treatment and want to understand how it fits alongside diabetes care. The right first step is a conversation with the clinicians who already manage your diabetes. They can tell you whether your current medicines are likely to be helping or hindering your weight goals.

If you are an adult without diabetes who wants medically supported weight management, the picture is simpler. Mounjaro is licensed for weight management in adults, used alongside a reduced-calorie diet and increased physical activity.¹ Treatment is prescription-only and supplied after a consultation reviewed by a GPhC-registered prescriber.

If you do have type 2 diabetes, the key point is coordination. Mounjaro is also licensed for type 2 diabetes, where it improves blood sugar control (HbA1c) and supports weight loss. If you have type 2 diabetes, treatment and monitoring are coordinated differently — tell your prescriber and your usual diabetes team so care stays joined up.¹

03

What you should not do

Do not stop, swap or change the dose of a diabetes medicine because you have read that another drug causes weight loss. Blood sugar can move quickly in either direction when treatment changes, and the safe plan depends on everything else you take.

Do not buy prescription medicines from sellers who offer to supply without a consultation or prescription. Counterfeit and unregulated products are a real risk, and the MHRA publishes counterfeit medicine alerts and runs the Yellow Card scheme for reporting problems.⁷

Do not treat low-cost supplements marketed as natural alternatives as equivalents. They carry no clinical oversight, dosing is not standardised, and the dramatic weight-loss claims made for them are not an established effect of the medicine.

04

A soft pathway if you are ready

If you are an adult who meets the licensed criteria and wants regulated private treatment, you can read about the Mounjaro pen, prices and consultation. All six doses are in stock, and the standard price of the 2.5mg starting pen is £169.99 (prices checked 10 October 2026). Our wider weight loss clinic page explains how the service works, and our overview of weight loss drugs compares the licensed options.

Related guides: Diabetic pen for weight loss and Diabetic injection to help weight loss and Amphetamine drugs for weight loss.

05 · Diabetes drugs and weight

How diabetes medicines relate to body weight

Diabetes medicines do not all treat weight in the same way, and that is the most important thing to understand before choosing a diabetic drug for weight loss. Each class of medicine was developed to lower blood sugar by a particular route. Weight change is sometimes a welcome side-benefit, sometimes neutral and sometimes unwelcome, depending on the medicine and the person.

This is why a blanket list of 'weight loss diabetic drugs' can mislead. A medicine that one person tolerates well and that helps them lose weight may do nothing for another person.

The medicines that attract the most attention for weight are the ones that mimic or act on gut hormones. These hormones tell the brain you are full, slow digestion and help the body respond to insulin. Tirzepatide, the active ingredient in Mounjaro, activates two natural gut-hormone receptors at once: GIP and GLP-1. Together these help regulate appetite, slow how quickly the stomach empties, and improve the way the body responds to insulin.¹

In practice, most people feel fuller sooner and less hungry between meals, which supports a reduced-calorie diet.¹ That last point matters. These medicines are not a substitute for dietary change and activity. They make it easier to stick to a smaller intake, and they are licensed on that basis.

Why weight matters in diabetes care

For many adults with type 2 diabetes, weight and blood sugar are closely linked, which is why clinicians pay attention to both. A medicine that helps with both goals can simplify treatment.

Your diabetes team will consider your blood sugar readings, other conditions, current prescriptions, kidney and heart health and your preferences. If you are unhappy with a weight effect from a medicine you take, say so. There may be alternatives, and a change made together with your clinicians is far safer than one made alone.

If you want to explore a specific diabetes medicine you take, ask your pharmacist or diabetes nurse, and read the patient leaflet that comes with it.

For a related angle, see our guide to the diabetic pen for weight loss, which explains what injectable pens do and do not offer.

06 · How tirzepatide works

How Mounjaro works on appetite and blood sugar

Mounjaro is the brand name for tirzepatide, a once-weekly injectable prescription medicine made by Eli Lilly. In the UK it is licensed for weight management in adults and for type 2 diabetes. It comes as a pre-filled multi-dose pen (KwikPen) in six strengths: 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg and 15mg.¹

Tirzepatide is the first treatment of its kind to activate two natural gut-hormone receptors at once: GIP and GLP-1. Together these help regulate appetite, slow how quickly the stomach empties, and improve the way the body responds to insulin.¹ Each of those effects is relevant to people with diabetes, which is why one medicine can be licensed for both diabetes and weight management.

Appetite

Appetite regulation is the effect people notice first. Most people feel fuller sooner and less hungry between meals, which supports a reduced-calorie diet.¹ It is not a switch that removes hunger entirely, and responses differ from person to person. Individual results vary.

Stomach emptying

Slowing how quickly the stomach empties helps you feel full for longer after eating. It is also the reason a few practical points apply, for example the way the medicine can reduce absorption of oral contraceptives. The SmPC advises switching to a non-oral method, or adding a barrier method (such as condoms), for 4 weeks after starting Mounjaro and for 4 weeks after each dose increase.¹

Insulin response

Improving how the body responds to insulin is the diabetes side of the picture. It is linked to the improvement in blood sugar control (HbA1c) described for people with type 2 diabetes.¹

What makes it different from single-action medicines

This dual action is what distinguishes Mounjaro from single-action GLP-1 medicines such as semaglutide (Wegovy/Ozempic).¹ Each is a licensed option with its own profile, and the right choice depends on your health, your goals and your prescriber's judgement.

Dosing in outline

Treatment begins at the lowest strength and moves up in steps under prescriber guidance. The pen is a weekly injection, and follow-up reviews check how you are tolerating each step. Never alter your dose yourself, and never use a pen for anything other than its licensed instructions. Read the patient information leaflet supplied with your pen.¹³

If you want to see how the injection compares in everyday terms with other injectable options, our page on the diabetic injection for weight loss goes through them in plain language.

07 · Mounjaro and type 2 diabetes

Mounjaro if you already have type 2 diabetes

If you have type 2 diabetes, Mounjaro is a licensed treatment for your condition as well as for weight, so the conversation with your diabetes team is a natural one to have. Mounjaro is also licensed for type 2 diabetes, where it improves blood sugar control (HbA1c) and supports weight loss.¹

The practical difference is coordination. If you have type 2 diabetes, treatment and monitoring are coordinated differently — tell your prescriber and your usual diabetes team so care stays joined up.¹ That means your GP surgery, diabetes nurse or specialist should know what you are taking, and your prescriber should know what else is on your medication list.

What to tell your prescriber

When you complete a consultation, be complete and accurate. List every diabetes medicine, including insulin and any tablets. Mention other conditions, allergies and any past reactions to similar medicines. A prescriber can only make a safe decision with the full picture. Payment is taken when you place the order; if the prescriber decides the treatment is not suitable, the order is refunded automatically in full.

Insulin and sulfonylureas

If you take insulin or a sulfonylurea, doses may need adjusting because of the risk of low blood sugar when another glucose-lowering medicine is added. This does not mean the medicines must never be combined. It means your diabetes team should review your doses and monitoring plan. Learn the signs of low blood sugar and what to do, and ask your team for guidance specific to you.

Monitoring does not stop

Starting a weight-management medicine does not replace your usual diabetes checks. Keep attending reviews, keep testing as advised and keep taking the other medicines your team has asked you to take. Treat any change in your blood sugar pattern as something to discuss promptly, not something to wait out.

NICE guidance for diabetes

NICE has published a separate appraisal of tirzepatide for treating type 2 diabetes, which is distinct from its weight-management appraisal.⁸ NHS diabetes pathways follow their own rules, so what is available to you through your GP or diabetes clinic may differ from what is available privately for weight management alone. The NHS also publishes a patient-focused page on tirzepatide covering both uses.⁵

When weight is the main goal

Some people with diabetes are mainly seeking help with weight. Others are mainly seeking better blood sugar control. These goals overlap but they are not identical, and the route to treatment may differ. Be clear with your clinicians about which matters most to you. If you are curious about the injectable route specifically, our guide to the diabetic injection to help weight loss explains how pens are used.

08 · NHS or private access

NHS or private: how access works

Mounjaro is available on the NHS, but access is being phased in over several years. NICE recommends it for adults with a BMI of at least 35 plus at least one weight-related condition, and the NHS primary-care rollout began in June 2025 with the highest-need groups first (initially BMI 40+ with four or more qualifying conditions).⁴⁶ Full rollout is expected to take years, which is why many people who meet the licensed criteria choose regulated private treatment rather than waiting.

What this means in practice

If you have diabetes, your route may begin with your GP or diabetes clinic. They can tell you whether you meet current local criteria and whether you are likely to be offered treatment through the NHS soon. Because the rollout is phased, local timing differs, and your surgery is the best source of up-to-date information.

If you decide not to wait, regulated private treatment is another route. Treatment is a prescription-only medicine, supplied after a consultation reviewed by a GPhC-registered prescriber. It is used alongside a reduced-calorie diet and increased physical activity. Individual results vary.

Licence versus NHS criteria

The licence and the NHS criteria are not the same thing. The licence describes who the medicine may be prescribed for. NHS criteria describe who the health service is currently funding, and they are narrower during the phased rollout. Someone may meet the licence but not yet meet NHS criteria. That gap is the reason private prescribing exists alongside the NHS.

Cost planning for private treatment

Costs depend on the dose you need. As of October 2026, the standard price of one 2.5mg pen is £169.99, and the first four pens (the 2.5mg, 5mg, 7.5mg and 10mg pens) total £959.96 at standard prices. A new customer's first order is £40 less with code FIRST40, and every later order is £25 less (code DOSE25). Prices were checked 10 October 2026.

Across the UK pharmacies we track, the price of the same dose can differ noticeably between providers. In our index, checked 10 October 2026, the smallest gap between providers for the same dose is £27 and the largest is £41. It is worth comparing like with like, including delivery and aftercare.

Supply you can check

Check that any pharmacy is registered. Ours is GPhC-registered, number 9012878, and you can look it up on the GPhC public register.¹² We supply genuine KwikPens via official LillyDirect supply, sourced from Eli Lilly's UK distribution.

Whichever route you choose, tell your diabetes team about it. Treatment from different places should never become separate silos.

09 · Wegovy, Ozempic and Saxenda

Other injectable options you may hear about

Mounjaro is not the only injectable medicine linked with diabetes and weight, and it helps to know the others by name so you can ask informed questions.

Wegovy (semaglutide)

Wegovy is a once-weekly semaglutide injection for weight management. Its pens come in 0.25mg, 0.5mg, 1mg, 1.7mg and 2.4mg strengths, and the dose steps up after at least four weeks, reaching the 2.4mg maintenance dose from week 17. The 2.4mg dose is the licensed maintenance dose for weight management.¹⁸ Availability varies, so check availability at the time of order.

Wegovy is a single-action GLP-1 medicine, unlike Mounjaro, which acts on both GIP and GLP-1 receptors.¹ NHS access to Wegovy runs through specialist weight-management services; ask your GP.

Ozempic (semaglutide)

Ozempic is semaglutide licensed for type 2 diabetes — it is not a UK weight-loss medicine, and prescribing it privately for weight loss is off-label. It is a single-action GLP-1 medicine, unlike Mounjaro. It is a different brand from Wegovy, with its own licence and dosing, and should be used as your prescriber directs. If you have been prescribed it for diabetes, do not change how you use it because of what you read about weight.

Saxenda and other liraglutide products

Liraglutide, sold as Saxenda and in other products, is supplied at a concentration of 6mg per millilitre. It is a daily injection, unlike once-weekly Mounjaro and Wegovy. For many people, how often they must inject is a practical factor in what they can stick with. Figures for liraglutide beyond this vary, so your prescriber can advise.

How to choose between them

The right choice depends on licence, your diabetes status, other health conditions, tolerability, availability and your own preferences about injection frequency. Do not choose by brand reputation alone. A prescriber who knows your history can weigh these factors, which is what a good consultation is for.

Tablets

Tablet forms of GLP-1-type medicines exist or are emerging, and they have their own clinical information.

For a broader view, our page on medicines used for weight loss lays out how the licensed options differ in plain terms.

10 · Safety and interactions

Safety, interactions and reporting problems

Mounjaro is a prescription-only medicine, and safe use depends on a proper consultation, honest answers and reading the patient information leaflet supplied with your pen.¹³

Low blood sugar with other diabetes medicines

If you take insulin or a sulfonylurea, doses may need adjusting because of the risk of low blood sugar. Do not make those changes yourself. Ask your diabetes team before you start, and agree how often to check your levels.

Contraception

Mounjaro can reduce absorption of oral contraceptives, because stomach emptying slows.⁷ The SmPC advises switching to a non-oral method, or adding a barrier method (such as condoms), for 4 weeks after starting Mounjaro and for 4 weeks after each dose increase. This applies to the pill only — implants, coils and injections are unaffected.

Mood and unusual thoughts

Regulators have looked specifically at whether GLP-1 medicines are linked to low mood or suicidal thoughts: the EMA's safety committee reviewed the evidence and concluded in 2024 that it does not support a causal link, and the MHRA keeps this under continuous review.¹⁷ Tell your prescriber about any history of depression, and seek help promptly if your mood drops or you have distressing thoughts during treatment.

If you have thoughts of harming yourself or ending your life, get help straight away. Call 999 or go to A&E if you are in immediate danger. In England you can call NHS 111 and choose the mental health option, any time. You can also call Samaritans free on 116 123, day or night. Tell your prescriber about any change in your mood while taking Mounjaro.

A symptom that is not on the UK patient leaflet list is not a listed side effect. If it is not listed, you should still discuss any new symptom with your prescriber. Report suspected side effects via the MHRA Yellow Card scheme.¹⁹

Counterfeits and unregulated sellers

Counterfeit medicine alerts are published by the MHRA.⁷ Be wary of anyone offering to supply without a consultation or prescription, and of social media sellers. Buy only from a registered pharmacy whose registration you can check on the GPhC register.¹²

Aftercare

Our aftercare includes ongoing monthly reviews, dose-titration and follow-up assessments by the prescribing team, and side-effect support. Repeat orders re-check suitability, and there is no auto-shipping. Support is available Monday to Friday, 9am to 5pm, by email at support@everydaymeds.co.uk, through the account portal chat, or by phone on 0333 207 0413.

11 · Storage and stopping

Storing your pen and what happens if you stop

Store unopened Mounjaro pens in the fridge until first use, and they keep until the printed expiry date. The usual fridge range is 2–8°C.¹³ If you are unsure about an unopened pen that has been out of the fridge, check the patient information leaflet and ask the pharmacy rather than guessing.

Once you start using a pen

Once in use, a pen can be kept out of the fridge at a temperature not above 30°C for up to 30 days after first use, and must then be thrown away. Do not use a pen that has been above 30°C or has been frozen.¹³ Keep the pen away from heat and direct sunlight, and follow the instructions supplied with it. For travel, deliveries and hot weather, temperature-controlled packaging helps us protect the pen on its way to you. Our delivery is free next-day, tracked, discreet and in cold-chain packaging.

Injection technique

Follow the pen's instructions for how to inject. Needles, a sharps bin and injection guidance are included with every order. If you are unsure, ask the prescribing team or your pharmacist before your first injection rather than after.

If you stop treatment

Tirzepatide has a half-life of about five days, so after a final dose it takes roughly four to five weeks to clear the system. There is no way to speed this up, and nothing needs doing while it clears.¹ If you have diabetes, tell your diabetes team that you have stopped so your other medicines and monitoring can be reviewed.

Why weight can change when treatment stops

Mounjaro manages weight; it does not cure the biology behind it. In SURMOUNT-4, people who stopped tirzepatide after 36 weeks regained on average 14% of body weight over the following year, while those who continued treatment lost a further 5.5% on average.¹⁴ Plan for that with your clinicians before you stop, not afterwards. Diet, activity and ongoing support all matter for keeping what you have achieved.

Missed injections and dose questions

If you miss a dose, take it as soon as you can within 4 days (96 hours) of the scheduled time, then carry on with your usual day; if more than 4 days have passed, skip the missed dose and take the next one on your normal day — never take two doses within 3 days of each other. Never double up to catch up.

Keeping records

Our free companion app, GLPTrackr, helps you track your journey on iOS and Android. It is a useful way to note injection dates, symptoms and questions to raise at your review, and it is handy to show to your diabetes team as well.

12 · Serious side effects

Serious side effects: when to get help straight away

Serious side effects are uncommon but need urgent attention. Seek immediate medical help for: severe, persistent stomach pain that may spread to your back, with or without vomiting (possible pancreatitis); pain in the upper right abdomen, fever or yellowing of skin/eyes (possible gallbladder problems); or signs of a severe allergic reaction such as swelling of the face or throat and difficulty breathing. If you take insulin or a sulfonylurea alongside Mounjaro, watch for low blood sugar (shakiness, sweating, confusion) — your prescriber may need to adjust those medicines.¹

13 · Ordering and what to ask

How ordering works and what to ask first

If you decide to explore private treatment, the process is designed to be clear, and you do not pay for the consultation. EverydayMeds is a GPhC-registered UK online pharmacy, registration 9012878, providing prescription treatments with free next-day delivery, and trusted by over 100,000 customers on their weight loss journey.

Three steps

The first step is a free online consultation: a short health questionnaire, with no charge and no obligation. The second is review by a GPhC-registered prescriber, not a scoring script. Payment is taken when you place the order; if the prescriber decides the treatment is not suitable, the order is refunded automatically in full. The third is dispensing and dispatch by our registered pharmacy, with same-day dispatch when ordered by 3pm, followed by free next-day tracked delivery. Saturday delivery is £14.99.

Price and payment

The price shown is the price paid, with no hidden fees. You can pay by Visa or Mastercard, with Klarna, or through pay-monthly options, and there are no subscriptions. A first year costs £2,711.88 at standard prices if you settle at 5mg, up to £3,599.88 at 15mg.

Questions worth asking your diabetes team first

• Are any of my current medicines likely to affect my weight?
• Would a change to my diabetes treatment be sensible, and who should make it?
• If I add a weight-management medicine, do my insulin or other doses need reviewing?
• How often should I check my blood sugar, and what should I do if it falls too low?
• Am I likely to qualify for NHS treatment soon, and should I wait?

Questions to ask any pharmacy

• Is the pharmacy registered, and can I verify it on the GPhC register?
• Is the medicine sourced from the manufacturer's official supply?
• What aftercare and reviews are included?
• What happens if the prescriber decides treatment is unsuitable?

Other things people ask about

If you are curious why stimulant-type medicines are not a sensible route, our guide to amphetamine drugs for weight loss explains the position. Whatever you choose, the safest route combines honest information, a proper prescriber review and joined-up care with the clinicians who know your diabetes.